| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 149.28B | 151.16B | 149.17B | 142.65B | 134.09B | 146.73B |
| Gross Profit | 33.64B | 33.31B | 29.22B | 31.27B | 25.91B | 26.56B |
| EBITDA | 14.65B | 15.47B | 12.03B | 14.95B | 10.89B | 11.46B |
| Net Income | 9.37B | 10.39B | 8.76B | 9.62B | 7.43B | 7.53B |
Balance Sheet | ||||||
| Total Assets | 175.19B | 196.41B | 191.18B | 179.69B | 174.53B | 177.74B |
| Cash, Cash Equivalents and Short-Term Investments | 61.53B | 39.43B | 45.34B | 65.24B | 42.98B | 44.42B |
| Total Debt | 1.16B | 12.12B | 800.00M | 288.00M | 396.00M | 5.73B |
| Total Liabilities | 69.22B | 86.84B | 80.18B | 78.52B | 80.18B | 87.19B |
| Stockholders Equity | 105.02B | 108.73B | 110.34B | 100.60B | 93.91B | 90.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.37B | -17.23B | 26.38B | 7.49B | -3.97B |
| Operating Cash Flow | 0.00 | -4.07B | -12.22B | 32.19B | 9.00B | -1.68B |
| Investing Cash Flow | 0.00 | 1.26B | -8.44B | -5.60B | -2.39B | -2.05B |
| Financing Cash Flow | 0.00 | 938.00M | -3.38B | -4.28B | -9.11B | 1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥939.27B | 16.97 | 6.61% | 1.58% | 3.17% | -23.53% | |
72 Outperform | ¥76.99B | 11.99 | 16.37% | 2.79% | 40.63% | 81.40% | |
70 Outperform | ¥209.66B | -49.70 | ― | 2.41% | 4.17% | -43.52% | |
69 Neutral | ¥208.15B | 10.37 | 9.02% | 3.11% | 5.22% | 8.82% | |
68 Neutral | ¥772.31B | 23.01 | ― | 1.43% | 9.69% | 34.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥123.87B | 5.42 | 12.54% | 1.84% | 17.17% | 33.30% |